CARDENE

This brand name is authorized in United States. It is also authorized in Netherlands, UK.

Active ingredients

The drug CARDENE contains one active pharmaceutical ingredient (API):

1	Nicardipine UNII K5BC5011K3 - NICARDIPINE HYDROCHLORIDE
	Nicardipine is a second generation slow calcium channel inhibitor, and belongs to the phenyl-dihydropyridine group. Nicardipine has a greater selectivity for L-type calcium channels in vascular smooth muscle than cardiac myocytes. Nicardipine produces smooth muscle relaxation and marked peripheral vasodilatation.
	Read more about Nicardipine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CARDENE IV Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)
CARDENE Hard capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA04	Nicardipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	14958, 15021
NL	Z-Index G-Standaard	14180375
NL	Z-Index G-Standaard, PRK	36765
US	FDA, National Drug Code	10122-313, 10122-314, 10122-325, 43066-016